scholarly journals STUDY OF THE POSSIBILITIES OF PREOPERATIVE CHEMOTHERAPY IN MULTIPLE METASTASIS OF COLORECTAL CANCER IN THE LIVER

2020 ◽  
Vol 1 (8(77)) ◽  
pp. 8-11
Author(s):  
Kh.D. Islamov ◽  
Sh.Kh. Niyozova

Preoperative chemotherapy (CT) in 35 patients with colorectal cancer (CRC) with liver metastases demonstrated a high frequency of objective effects - in 22 (62.9%) patients, stabilization was noted in 10 (28.6%) cases. With bilobar liver metastases and the use of oxaliplatin-containing regimens, partial regression was 62.9%. Side effects in most cases were clinically insignificant, no deaths were observed. The results obtained demonstrate the possibility of performing extended surgical operations in the majority of CRC patients with multiple liver metastases after preoperative CT.

2013 ◽  
Author(s):  
Yasushi Ichikawa ◽  
Ayumu Goto ◽  
Noriotoshi Kobayashi ◽  
Motohiko Tokuhisa ◽  
Takashi Ishikawa ◽  
...  

2011 ◽  
Vol 44 (4) ◽  
pp. 490-496
Author(s):  
Shigeru Ottomo ◽  
Toshiki Rikiyama ◽  
Shinichi Egawa ◽  
Yu Katayose ◽  
Fuyuhiko Motoi ◽  
...  

2008 ◽  
Vol 32 (9) ◽  
pp. 2057-2069 ◽  
Author(s):  
Kuniya Tanaka ◽  
Hiroshi Shimada ◽  
Chizuru Matsumoto ◽  
Kenichi Matsuo ◽  
Kazuhisa Takeda ◽  
...  

Medicine ◽  
2017 ◽  
Vol 96 (7) ◽  
pp. e6174 ◽  
Author(s):  
Chan W. Kim ◽  
Jong L. Lee ◽  
Yong S. Yoon ◽  
In J. Park ◽  
Seok-Byung Lim ◽  
...  

2020 ◽  
Author(s):  
Lionel Chen ◽  
Nicholas L. Syn ◽  
Brian K. P. Goh ◽  
Peng Chung Cheow ◽  
Prema Raj ◽  
...  

Abstract Background Resection of colorectal liver metastases (CLM) has been established as the standard of care. This study aims to compare the change in clinicopathological characteristics of patients who underwent curative resection of CLM across two time periods – 2000 to 2010 (P1) and 2011 to 2016 (P2) and evaluate the prognostic impact of these characteristics on survival outcomes. Methods Patients who undergo liver resection for CLM at Singapore General Hospital from January 2000 to December 2016 were identified from a prospectively maintained database. The primary end point was overall survival. Results There were 183/318 (57.5%) patients and 135/318 (42.5%) patients in P1 and P2 respectively. There was a lower proportion of patients who had nodal metastases from primary colorectal cancer and clinical risk score (CRS) less than 3 in P2 when compared to P1. There was no difference in survival between both time periods. Independent predictors of survival for the cohort were CEA levels ≥200ng/ml, primary tumour grade and lymph nodal status. Independent predictors of poor survival in P1 were poorly differentiated colorectal cancer and nodal metastases while in P2, independent predictors of poor survival were multiple liver metastases and nodal metastases.Conclusion Nodal metastases from primary colorectal cancer is an independent predictor of poor survival across time for resectable CLM. Although there is no difference in survival between the two time periods, patients with multiple liver metastases should be carefully considered prior to surgery as it is also an independent predictor of overall survival.


Sign in / Sign up

Export Citation Format

Share Document